Search Results

S107 10mg  | ≥99%

CSNpharm

S107 is a RyR-selective 1,4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

More Information Supplier Page

S107 50mg  | ≥99%

CSNpharm

S107 is a RyR-selective 1,4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

More Information Supplier Page

BTB1 10mg  | ≥99%

CSNpharm

BTB1 an ATP-competitive and selective inhibitor of the mitotic motor protein Kif18A with IC50 value of 1.7 μM.

More Information Supplier Page

BTB1 5mg  | ≥99%

CSNpharm

BTB1 an ATP-competitive and selective inhibitor of the mitotic motor protein Kif18A with IC50 value of 1.7 μM.

More Information Supplier Page

BTB1 100mg  | ≥99%

CSNpharm

BTB1 an ATP-competitive and selective inhibitor of the mitotic motor protein Kif18A with IC50 value of 1.7 μM.

More Information Supplier Page

BTB1 1mg  | ≥99%

CSNpharm

BTB1 an ATP-competitive and selective inhibitor of the mitotic motor protein Kif18A with IC50 value of 1.7 μM.

More Information Supplier Page

BTB1 50mg  | ≥99%

CSNpharm

BTB1 an ATP-competitive and selective inhibitor of the mitotic motor protein Kif18A with IC50 value of 1.7 μM.

More Information Supplier Page